Clinical Report: Correction: Updated Supplement for the German Birth Cohort Study

Overview

A correction was issued because Supplement 1 accompanying the original investigation of atopic dermatitis incidence and remission in a German birth cohort appeared in an erroneous form in the December 8, 2025, publication. The supplied context does not describe the corrected supplement’s contents or report changes to the study’s findings.

Background

Atopic dermatitis is the subject of research on incidence and remission across populations, including participants in birth cohorts. Supplementary materials can provide information accompanying an original investigation. The correction notice identifies an error in Supplement 1 but does not specify its nature or the corrected material. Other supplied correction notices concern separate articles and should not be interpreted as changes to the German birth cohort study.

Data Highlights

The source provides no numerical results or details of the corrected Supplement 1. It states that Supplement 1 appeared in an erroneous form in the December 8, 2025, publication and that a correction was issued.

Key Findings

• The correction applies to the original investigation of atopic dermatitis incidence and remission among participants in a German birth cohort.
• Supplement 1 appeared in an erroneous form in the December 8, 2025, publication.
• A correction was issued for the supplement.
• The supplied notice does not describe the specific error or reproduce the corrected supplement.
• The related notices about biologic comparisons, lebrikizumab, and pediatric dietary and environmental factors concern separate articles.

Clinical Implications

The correction notice identifies a publication issue in Supplement 1 but provides no clinical findings or practice recommendations. Readers seeking the corrected supplementary information should consult the corrected original article.

Conclusion

The notice records a correction to Supplement 1 of the German birth cohort investigation. No further details about the correction or its effect on the study findings are provided in the supplied material.

Related Resources & Content

1. JAMA Network Open, Incidence and Remission of Atopic Dermatitis in a German Birth Cohort
2. Dermatology and Therapy, Amendment: An Expert Review of Long-Term Effectiveness of Biologics in Moderate-to-Severe Atopic Dermatitis Using Indirect Comparison Techniques
3. Dermatology and Therapy, Correction: Long-Term Efficacy and Safety of Lebrikizumab in Individuals with Moderate-to-Severe Atopic Dermatitis: Findings from a Three-Year Extension Study (ADjoin)
4. Frontiers in Pediatrics — Investigating Dietary and Environmental Influences on Atopic Dermatitis in Children: Management Strategies and Implications
5. Frontiers in Pediatrics — Advancements in Biomarkers for Assessing Severity, Persistence, and Non-Invasive Monitoring of Pediatric Atopic Dermatitis
6. Incidence and Remission of Atopic Dermatitis in a German Birth Cohort
7. Living EuroGuiDerm Guideline for the systemic treatment of Atopic Eczema | EDFG
8. Full article: Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis: a network meta-analysis of phase 3–4 randomized trials